Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Pegtarazimod by ReAlta Life Sciences for Coronavirus Disease 2019 (COVID-19) Associated Acute Lung Injury: Likelihood of Approval
Pegtarazimod is under clinical development by ReAlta Life Sciences and currently in Phase I for Coronavirus Disease 2019 (COVID-19) Associated...